Literature DB >> 9833919

Time trends and age-period-cohort effects on the incidence of primary liver cancer in a well-defined French population: 1976-1995.

A M Benhamiche1, C Faivre, A Minello, F Clinard, E Mitry, P Hillon, J Faivre.   

Abstract

BACKGROUND/AIMS: There is growing interest worldwide in primary liver cancer. The aim of this study was to describe the incidence of this cancer over a 20-year period in a well-defined French population.
METHODS: Time trends by 4-year period were studied by sex, age group, place of residence, histological type and associated cirrhosis. Trends were also analysed using the age-period-cohort model.
RESULTS: Primary liver cancer incidence in men increased from 7.5/100000 for the period 1976-79 to 10.2/100000 for the period 1992-95. The mean annual variation was +2.2%, (p<0.05). The increase in incidence was seen mainly in the 55-64 and 65-74 age groups and concerned hepatocellular carcinomas. In men, the increase in incidence rates with time was observed mainly in rural areas, whereas incidence rates in urban areas remained stable. The rise in incidence was due mostly to an increase in primary liver cancer with cirrhosis, in relation to a progressive increase in post-hepatitic cirrhosis and a recent increase in alcoholic cirrhosis. The estimated cumulative risk for the life span 30-74 years increased from 0.8% for the 1904-1908 cohort to 2.1% for the 1934-1938 cohort. There was no significant trend in female rates.
CONCLUSIONS: In France, incidence rates for primary liver cancer are increasing in men, whilst they are remaining stable in women. Our data confirm the primary importance of alcohol in the aetiology of this cancer. Further studies are necessary to unravel the respective roles of alcohol and hepatitis C virus in the increasing incidence of primary liver cancer.

Entities:  

Mesh:

Year:  1998        PMID: 9833919     DOI: 10.1016/s0168-8278(98)80262-6

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  9 in total

1.  Diagnostic value of PIVKA-II and alpha-fetoprotein in hepatitis B virus-associated hepatocellular carcinoma.

Authors:  Seung In Seo; Hyoung Su Kim; Won Jin Kim; Woon Geon Shin; Doo Jin Kim; Kyung Ho Kim; Myoung Kuk Jang; Jin Heon Lee; Joo Seop Kim; Hak Yang Kim; Dong Joon Kim; Myung Seok Lee; Choong Kee Park
Journal:  World J Gastroenterol       Date:  2015-04-07       Impact factor: 5.742

2.  Expression of lysosome-associated protein transmembrane 4B-35 in cancer and its correlation with the differentiation status of hepatocellular carcinoma.

Authors:  Cong Peng; Rou-Li Zhou; Gen-Ze Shao; Jing-An Rui; Shao-Bin Wang; Ming Lin; Sha Zhang; Zi-Feng Gao
Journal:  World J Gastroenterol       Date:  2005-05-14       Impact factor: 5.742

3.  Risk factors for hepatocellular carcinoma in Turkey.

Authors:  O Uzunalimoğlu; C Yurdaydin; H Cetinkaya; H Bozkaya; T Sahin; S Colakoğlu; E Tankurt; M Sarioğlu; S Ozenirler; H Akkiz; N Tözün; H Değertekin; A Okten
Journal:  Dig Dis Sci       Date:  2001-05       Impact factor: 3.199

Review 4.  Treatment of hepatocellular carcinoma with intra-arterial injection of radionuclides.

Authors:  Jean-Luc Raoul; Eveline Boucher; Yan Rolland; Etienne Garin
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-01       Impact factor: 46.802

5.  Rising costs and hospital admissions for hepatocellular carcinoma in Portugal (1993-2005).

Authors:  Rui Tato Marinho; José Giria; Miguel Carneiro Moura
Journal:  World J Gastroenterol       Date:  2007-03-14       Impact factor: 5.742

6.  Changes in survival patterns in urban Chinese patients with liver cancer.

Authors:  Xi-Shan Hao; Ke-Xin Chen; Peizhong Peter Wang; Tom Rohan
Journal:  World J Gastroenterol       Date:  2003-06       Impact factor: 5.742

7.  Viral hepatitis and hepatocellular carcinoma.

Authors:  Peter P Michielsen; Sven M Francque; Jurgen L van Dongen
Journal:  World J Surg Oncol       Date:  2005-05-20       Impact factor: 2.754

8.  Long-Term Trends of Liver Cancer Incidence and Mortality in China 1990-2017: A Joinpoint and Age-Period-Cohort Analysis.

Authors:  Fang Wang; Sumaira Mubarik; Yu Zhang; Lu Wang; Yafeng Wang; Chuanhua Yu; Hao Li
Journal:  Int J Environ Res Public Health       Date:  2019-08-12       Impact factor: 3.390

Review 9.  Hepatocellular carcinoma in the world and the middle East.

Authors:  H Poustchi; Sg Sepanlou; S Esmaili; N Mehrabi; A Ansarymoghadam
Journal:  Middle East J Dig Dis       Date:  2010-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.